Viewing nowSimbacor Tablet (Simvastatin)
Simvastatin 20mg
Tablet · Prescription medication
Celicx Co., Ltd.

MFDS item code 200401881 · Notified 2004.01.26 · Insurance code 646201110
Improvement of hyperlipidemia (including pediatric familial hyperlipidemia); reduction of cardiovascular disease risk
This medication helps to reduce the risk of cardiovascular disease. It decreases the risk of coronary heart disease mortality, non-fatal myocardial infarction, and stroke in adult patients with a history of cardiovascular diseases such as coronary artery disease, diabetes, peripheral vascular disease, and stroke. It also reduces the risk that may occur after coronary and non-coronary vascular revascularization. It is used to treat hyperlipidemia, lowering bad cholesterol and triglyceride levels and increasing good cholesterol in patients with primary hypercholesterolemia and mixed dyslipidemia. It is particularly helpful in controlling blood cholesterol levels in pediatric patients with heterozygous familial hypercholesterolemia, in conjunction with dietary therapy. Overall, this medication is used to improve cardiovascular health and reduce risk factors.
Patients must follow a standard cholesterol-lowering diet before and during treatment with this drug. 1. Reduction of cardiovascular risk Adult patients at high risk of coronary heart disease events because of a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended initial starting dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial starting dose is 20 mg of this drug once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this drug. The recommended dose is 5 ~ 40 mg of this drug once daily in the evening. Adjust the dose as appropriate based on the baseline LDL cholesterol level before starting treatment, the treatment goal, and the patient's response to the drug. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter to adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, use of the 80 mg dose of this drug, particularly during the first year of treatment, is restricted to patients who have taken 80 mg of this drug for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). 2) Refer below for recommended doses in patients receiving this drug concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in specific patient groups (i.e., patients with homozygous familial hypercholesterolemia, older patients, and patients with renal impairment) (see 6. Interactions under Precautions for Use). (1) Administration to patients with homozygous familial hypercholesterolemia Based on the results of controlled clinical trials, administer 40 mg of this drug once daily in the evening to patients with homozygous familial hypercholesterolemia. Administer this drug in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not available. (2) In older patients, a daily dose of 20 mg of this drug may achieve the maximum reduction in cholesterol levels. (3) Administration to patients receiving verapamil, diltiazem, or dronedarone When this drug is administered concomitantly to patients receiving verapamil, diltiazem, or dronedarone, the dose of this drug should not exceed 10 mg per day. (4) Administration to patients receiving amiodarone, amlodipine, or ranolazine When this drug is administered concomitantly to patients receiving amiodarone, amlodipine, or ranolazine, the dose of this drug should not exceed 20 mg per day. (5) Concomitant use with other lipid-lowering agents This drug is effective when used alone or concomitantly with bile acid sequestrants. When this drug is administered concomitantly with fibrates (excluding gemfibrozil (see 2. Patients in whom this drug is contraindicated under Precautions for Use) and fenofibrate), the dose of this drug should not exceed 10 mg per day. (6) Administration to patients with renal impairment Because this drug is not excreted extensively by the kidneys, no dose adjustment is required in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, start with an initial dose of 5 mg per day and monitor carefully.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this drug once daily in the evening. The recommended dose range is 10 ~ 40 mg per day, and the recommended maximum dose is 40 mg per day. Adjust the dose appropriately for each patient according to the recommended treatment goals. Allow an interval of 4 weeks or longer between dose adjustments.
This medication is used to lower blood cholesterol levels. Caution is required when taking this medication due to the risk of muscle problems. There is a higher risk of muscle damage, especially when taking high doses or in conjunction with certain other medications. Patients with liver function problems or abnormally high liver enzyme levels should not take this medication. Women who are pregnant or breastfeeding should not take this medication, and women who may become pregnant must use contraception during treatment. This medication should not be taken with certain strong medications, as it may increase the risk of muscle damage. Therefore, patients should inform healthcare providers of any other medications being taken. Patients with excessive alcohol intake or liver or kidney diseases should be especially cautious when taking this medication and should undergo regular checks to monitor their condition. Elderly patients and women are at a higher risk of muscle problems, so caution is necessary during treatment. If symptoms like muscle pain, muscle weakness, or discomfort occur while taking this medication, it is important to consult a doctor immediately, and medication can be stopped if necessary. This medication can affect liver function test results, so regular liver function tests are recommended. Furthermore, if prescribed a new medication during the time this medication is taken, it is important to inform healthcare providers and to avoid certain foods such as grapefruit juice. Blood sugar levels may increase while taking this medication, so patients at risk of diabetes should regularly check their blood sugar. Children or adolescents below certain ages should not take this medication, and should consult healthcare providers regarding its impact on growth and development. In case of overdose, contact a medical institution immediately for appropriate treatment. This medication should be kept out of reach of children and should be stored safely in its original container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius.
Yellow-brown oval film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSimvastatin 20mg
Tablet · Prescription medication
Celicx Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Jongkundang Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Dong-A ST Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Korea Hutech Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Yuhan Corporation

Simvastatin 40mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Dongsung Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.